MY179921A - Infection protection agent - Google Patents
Infection protection agentInfo
- Publication number
- MY179921A MY179921A MYPI2015702737A MYPI2015702737A MY179921A MY 179921 A MY179921 A MY 179921A MY PI2015702737 A MYPI2015702737 A MY PI2015702737A MY PI2015702737 A MYPI2015702737 A MY PI2015702737A MY 179921 A MY179921 A MY 179921A
- Authority
- MY
- Malaysia
- Prior art keywords
- protection agent
- infection
- infection protection
- lactadherin
- phylactic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Abstract
Provided is an infection phylactic agent containing, as an active ingredient, lactadherin and/or a product prepared by decomposition of lactadherin with a protease. The infection phylactic agent can be produced from the milk of a mammal by a simple process at low cost, and thus can be safely ingested routinely.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013046737A JP6346405B2 (en) | 2013-03-08 | 2013-03-08 | Infection preventive |
Publications (1)
Publication Number | Publication Date |
---|---|
MY179921A true MY179921A (en) | 2020-11-19 |
Family
ID=51491438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015702737A MY179921A (en) | 2013-03-08 | 2014-03-07 | Infection protection agent |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP6346405B2 (en) |
CN (1) | CN105025914B (en) |
AU (1) | AU2014226864B2 (en) |
HK (1) | HK1210942A1 (en) |
MY (1) | MY179921A (en) |
NZ (1) | NZ711985A (en) |
TW (1) | TWI646969B (en) |
WO (1) | WO2014136931A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6656172B2 (en) * | 2014-12-25 | 2020-03-04 | 一般財団法人糧食研究会 | Emulsion stabilizer and emulsion stabilization method using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007026669A1 (en) * | 2005-09-02 | 2007-03-08 | Shizuoka Prefectural Universities Corporation | Method for determination of recognition specificity of virus for receptor sugar chain |
JP2008031156A (en) * | 2006-07-07 | 2008-02-14 | National Univ Corp Shizuoka Univ | Antiviral agent |
WO2009001805A1 (en) * | 2007-06-28 | 2008-12-31 | National University Corporation Shizuoka University | Novel artificial n-linked sialo-sugar chain-containing polymer and method for producing the same |
EP2389952A1 (en) * | 2010-05-31 | 2011-11-30 | Rotalactis Srl | Lactadherin-derived peptides as antiviral agents |
WO2012149254A2 (en) * | 2011-04-28 | 2012-11-01 | The Feinstein Institute For Medical Research | Mfg-e8 and uses thereof |
-
2013
- 2013-03-08 JP JP2013046737A patent/JP6346405B2/en active Active
-
2014
- 2014-03-07 WO PCT/JP2014/055931 patent/WO2014136931A1/en active Application Filing
- 2014-03-07 CN CN201480012689.8A patent/CN105025914B/en not_active Expired - Fee Related
- 2014-03-07 MY MYPI2015702737A patent/MY179921A/en unknown
- 2014-03-07 AU AU2014226864A patent/AU2014226864B2/en not_active Ceased
- 2014-03-07 NZ NZ711985A patent/NZ711985A/en not_active IP Right Cessation
- 2014-03-10 TW TW103108236A patent/TWI646969B/en active
-
2015
- 2015-11-27 HK HK15111714.5A patent/HK1210942A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN105025914B (en) | 2020-02-18 |
TWI646969B (en) | 2019-01-11 |
HK1210942A1 (en) | 2016-05-13 |
JP6346405B2 (en) | 2018-06-20 |
AU2014226864A1 (en) | 2015-09-24 |
TW201446257A (en) | 2014-12-16 |
CN105025914A (en) | 2015-11-04 |
AU2014226864B2 (en) | 2018-09-13 |
NZ711985A (en) | 2020-06-26 |
WO2014136931A1 (en) | 2014-09-12 |
JP2014172862A (en) | 2014-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016004945A (en) | Processes for the preparation of pesticidal compounds. | |
MX355461B (en) | A stabilized pemetrexed formulation. | |
PH12015501888A1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
MX2015012737A (en) | Liquid stable bovine virus vaccines. | |
WO2013135494A3 (en) | Lithographic apparatus | |
EP3137145A4 (en) | Resuscitation arrangement comprising mask, monitoring arrangements, and digital module detachably arranged as part of the mask | |
PH12015501933B1 (en) | Novel pyridine derivatives | |
MX2015011837A (en) | Co-crystals of pyrimethanil and selected dithiine tetracarboximide. | |
MX2017006709A (en) | Agent for preventing or improving symptoms caused by imbalance of sex hormones. | |
PH12016501865A1 (en) | Pyridine-2-amides useful as cb2 agonists | |
NZ712582A (en) | Medical accessory holder | |
MX2017007577A (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof. | |
IN2014DN08496A (en) | ||
MX368268B (en) | Hiv treatment formulation of atazanavir and cobicistat. | |
MX2017006712A (en) | Matrix metalloproteinase production inhibitor. | |
MX363458B (en) | Novel tetrazolone derivatives. | |
MX2016004328A (en) | Immunopotentiator. | |
MX351860B (en) | Injection closure system. | |
MY179921A (en) | Infection protection agent | |
WO2015073788A3 (en) | Methods and compositions for the treatment of hcmv | |
MX2016011413A (en) | Formulations comprising polymeric xyloglucan as a carrier for agriculturally beneficial agents. | |
IN2015DN00962A (en) | ||
MX2015011954A (en) | Nitrogen containing surfactants with alkoxylation on the hydroxyl group of fatty chains. | |
WO2015051268A3 (en) | Hiv protease inhibitors against picornavirus infection | |
MX2016002186A (en) | Process for preparing dronedarone and salts thereof. |